Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$16.17M
9 trades · 3 insiders
Net · 90d
$-16.17M
Insiders on file
40
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| PFEIFFER GARY M | Director | 53 | $0 | $7.25M | 2026-10-26 |
| DELANEY MARK E | SVP & Chief Commercial Officer | 42 | $0 | $2.67M | 2026-10-21 |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | 62 | $0 | $5.19M | 2026-10-21 |
| Lassiter Wright III | Director | 17 | $0 | $0 | 2026-10-21 |
| SAMAD SAM | Executive Vice President & CFO | 34 | $0 | $0 | 2026-10-21 |
| Gregg Vicky B | Director | 36 | $0 | $762.0K | 2026-10-21 |
| Plewman Patrick | SVP for Diagnostic Services | 61 | $0 | $4.60M | 2026-10-21 |
| CARTER ROBERT B | Director | 9 | $0 | $0 | 2026-10-21 |
| MAIN TIMOTHY L | Director | 19 | $253.5K | $0 | 2026-10-21 |
| WENTWORTH TIMOTHY C | Director | 5 | $0 | $0 | 2026-10-01 |
| Davis J. E. | SVP, Regional Businesses | 133 | $0 | $54.12M | 2026-09-01 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 240 | $0 | $89.52M | 2026-08-28 |
| Diaz Luis | Director | 4 | $0 | $0 | 2026-05-20 |
| Doi Tracey | Director | 6 | $0 | $0 | 2026-05-20 |
| MORRISON DENISE M | Director | 13 | $0 | $0 | 2026-05-20 |
| RING TIMOTHY M | Director | 119 | $0 | $3.00M | 2026-05-20 |
| Doherty Catherine T. | SVP, Regional Businesses | 211 | $0 | $76.65M | 2026-03-05 |
| Deppe Michael J | VP, Corp. Controller & CAO | 78 | $0 | $6.97M | 2026-03-04 |
| GARDNER MARK A | SVP of Molecular Gen & Oncol | 7 | $0 | $0 | 2024-09-24 |
| WILENSKY GAIL R | Director | 50 | $0 | $9.72M | 2023-05-17 |
| RUSCKOWSKI STEPHEN H | President and CEO | 149 | $1.43M | $203.16M | 2023-03-06 |
| EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | 35 | $0 | $555.1K | 2022-03-07 |
| GUINAN MARK | Senior Vice President & CFO | 80 | $222.0K | $32.18M | 2022-03-07 |
| Torley Helen | Director | 7 | $0 | $0 | 2021-05-25 |
| Mendez Manuel O. | SVP & Chief Commercial Officer | 6 | $0 | $0 | 2021-02-17 |
| STANZIONE DANIEL | Director | 61 | $0 | $12.12M | 2020-11-23 |
| Cunningham Everett | SVP, Commercial | 73 | $0 | $20.61M | 2019-03-04 |
| Klug Robert A | VP, Corporate Controller | 37 | $0 | $119.9K | 2019-03-01 |
| BRITELL JENNE K | Director | 33 | $0 | $3.77M | 2018-06-04 |
| LEIDEN JEFFREY M | Director | 30 | $0 | $890.2K | 2018-05-29 |
| Cohen Jon R | SVP, Hosp. Svcs. Bus. and CMO | 83 | $0 | $30.32M | 2018-03-08 |
| ZIEGLER JOHN B | Director | 57 | $0 | $6.05M | 2017-02-22 |
| BALDWIN JOHN C MD | Director | 25 | $0 | $3.14M | 2015-08-12 |
| BONGIORNO THOMAS F | VP and Corporate Controller | 52 | $0 | $4.58M | 2015-03-02 |
| Haydon John B. | SVP, Operations | 5 | $0 | $0 | 2014-02-13 |
| BUEHLER WILLIAM F | Director | 20 | $0 | $5.11M | 2014-02-12 |
| ORDONEZ KATHY | SVP, Discovery & Development | 9 | $0 | $0 | 2013-03-31 |
| HAGEMANN ROBERT | SVP & Chief Financial Officer | 24 | $0 | $12.58M | 2013-03-05 |
| MOHAPATRA SURYA N | Chairman, President & CEO | 19 | $0 | $27.73M | 2012-04-30 |
| Miller Joan Elizabeth | SVP-Oncology & Neurology Srvcs | 15 | $0 | $1.67M | 2012-02-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| PFEIFFER GARY M | Director | S Sale | 2026-10-26 | 2026-10-28 | 1,203 | $243.00 | $292.3K | 29,802 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2026-10-21 | 2026-10-23 | 90 | $235.94 | $21.2K | 33,568 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | L Small acq | 2026-10-21 | 2026-10-23 | 41 | $235.94 | $9.7K | 15,334 | SEC↗ |
| MAIN TIMOTHY L | Director | L Small acq | 2026-10-21 | 2026-10-23 | 18 | $235.94 | $4.2K | 22,478 | SEC↗ |
| Lassiter Wright III | Director | L Small acq | 2026-10-21 | 2026-10-23 | 6 | $235.96 | $1.4K | 10,329 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small acq | 2026-10-21 | 2026-10-23 | 33 | $235.94 | $7.8K | 13,619 | SEC↗ |
| Gregg Vicky B | Director | A Award | 2026-10-21 | 2026-10-23 | 63 | $235.94 | $14.9K | 18,449 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | L Small acq | 2026-10-21 | 2026-10-23 | 25 | $235.94 | $5.9K | 10,360 | SEC↗ |
| CARTER ROBERT B | Director | L Small acq | 2026-10-21 | 2026-10-23 | 10 | $235.93 | $2.4K | 3,874 | SEC↗ |
| WENTWORTH TIMOTHY C | Director | A Award deriv | 2026-10-01 | 2026-10-02 | 135 | — | $0 | 477 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2026-09-01 | 2026-09-03 | 10,000 | $242.72 | $2.43M | 122,423 | SEC↗ |
| Davis J. E. | CEO and President, Director | S Sale | 2026-09-01 | 2026-09-03 | 10,000 | $242.72 | $2.43M | 122,423 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise deriv | 2026-08-28 | 2026-08-31 | 22,677 | $112.17 | $2.54M | 0 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise | 2026-08-28 | 2026-08-31 | 22,677 | $112.17 | $2.54M | 60,234 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-08-28 | 2026-08-31 | 16,010 | $242.88 | $3.89M | 44,224 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-08-28 | 2026-08-31 | 6,237 | $243.63 | $1.52M | 37,987 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-08-28 | 2026-08-31 | 430 | $244.51 | $105.1K | 37,557 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | G Gift | 2026-08-28 | 2026-08-31 | 1,000 | — | $0 | 36,557 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise deriv | 2026-08-28 | 2026-08-31 | 22,677 | $112.17 | $2.54M | 0 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | G Gift | 2026-08-28 | 2026-08-31 | 1,000 | — | $0 | 36,557 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-08-28 | 2026-08-31 | 430 | $244.51 | $105.1K | 37,557 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-08-28 | 2026-08-31 | 6,237 | $243.63 | $1.52M | 37,987 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-08-28 | 2026-08-31 | 16,010 | $242.88 | $3.89M | 44,224 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise | 2026-08-28 | 2026-08-31 | 22,677 | $112.17 | $2.54M | 60,234 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | S Sale | 2026-07-28 | 2026-07-29 | 1,600 | $235.18 | $376.3K | 10,335 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | S Sale | 2026-07-28 | 2026-07-29 | 1,600 | $235.18 | $376.3K | 10,335 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | L Small acq | 2026-07-22 | 2026-07-27 | 34 | $206.81 | $7.0K | 11,935 | SEC↗ |
| Lassiter Wright III | Director | L Small acq | 2026-07-22 | 2026-07-27 | 6 | $206.81 | $1.2K | 10,323 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2026-07-22 | 2026-07-27 | 102 | $206.81 | $21.1K | 33,478 | SEC↗ |
| MAIN TIMOTHY L | Director | L Small acq | 2026-07-22 | 2026-07-27 | 21 | $206.81 | $4.3K | 22,460 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | L Small acq | 2026-07-22 | 2026-07-27 | 46 | $206.81 | $9.5K | 15,293 | SEC↗ |
| Gregg Vicky B | Director | A Award | 2026-07-22 | 2026-07-27 | 72 | $206.81 | $14.9K | 18,386 | SEC↗ |
| CARTER ROBERT B | Director | L Small acq | 2026-07-22 | 2026-07-27 | 11 | $206.80 | $2.3K | 3,864 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small acq | 2026-07-22 | 2026-07-27 | 37 | $206.81 | $7.7K | 13,557 | SEC↗ |
| WENTWORTH TIMOTHY C | Director | A Award deriv | 2026-07-01 | 2026-07-02 | 144 | — | $0 | 342 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise deriv | 2026-06-04 | 2026-06-08 | 4,827 | $121.81 | $588.0K | 0 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise deriv | 2026-06-04 | 2026-06-08 | 3,320 | $127.73 | $424.1K | 0 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S Sale | 2026-06-04 | 2026-06-08 | 8,147 | $200.00 | $1.63M | 13,510 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 2026-06-04 | 2026-06-08 | 3,320 | $127.73 | $424.1K | 16,830 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 2026-06-04 | 2026-06-08 | 4,827 | $121.81 | $588.0K | 21,657 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2026-06-01 | 2026-06-02 | 10,000 | $194.14 | $1.94M | 132,423 | SEC↗ |
| PFEIFFER GARY M | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 31,005 | SEC↗ |
| MORRISON DENISE M | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 11,929 | SEC↗ |
| Lassiter Wright III | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 10,317 | SEC↗ |
| RING TIMOTHY M | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 31,140 | SEC↗ |
| Doi Tracey | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 7,748 | SEC↗ |
| WENTWORTH TIMOTHY C | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 1,358 | SEC↗ |
| MAIN TIMOTHY L | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 27,439 | SEC↗ |
| Diaz Luis | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 5,196 | SEC↗ |
| Gregg Vicky B | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 18,314 | SEC↗ |
| CARTER ROBERT B | Director | A Award | 2026-05-20 | 2026-05-21 | 1,142 | — | $0 | 3,853 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | L Small acq | 2026-04-20 | 2026-04-24 | 37 | $194.70 | $7.2K | 11,901 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small acq | 2026-04-20 | 2026-04-24 | 39 | $194.70 | $7.6K | 13,490 | SEC↗ |
| Lassiter Wright III | Director | L Small acq | 2026-04-20 | 2026-04-24 | 6 | $194.70 | $1.2K | 9,063 | SEC↗ |
| CARTER ROBERT B | Director | L Small acq | 2026-04-20 | 2026-04-24 | 7 | $194.70 | $1.4K | 2,711 | SEC↗ |
| Gregg Vicky B | Director | A Award | 2026-04-20 | 2026-04-24 | 68 | $194.70 | $13.2K | 17,172 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | L Small acq | 2026-04-20 | 2026-04-24 | 49 | $194.70 | $9.5K | 15,247 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2026-04-20 | 2026-04-24 | 108 | $194.70 | $21.0K | 33,376 | SEC↗ |
| WENTWORTH TIMOTHY C | Director | A Award deriv | 2026-04-01 | 2026-04-02 | 198 | — | $0 | 198 | SEC↗ |
| WENTWORTH TIMOTHY C | Director | A Award | 2026-03-09 | 2026-03-11 | 215 | — | $0 | 215 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2026-03-05 | 2026-03-06 | 2,855 | $206.21 | $588.7K | 15,198 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-03-05 | 2026-03-06 | 3,878 | $206.21 | $799.7K | 37,557 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-03-05 | 2026-03-06 | 5,558 | $206.21 | $1.15M | 67,122 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S Sale | 2026-03-04 | 2026-03-06 | 2,628 | $204.86 | $538.4K | 13,441 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A Award | 2026-03-04 | 2026-03-06 | 6,200 | $204.86 | $1.27M | 16,069 | SEC↗ |
| Deppe Michael J | SVP, Corp. Controller & CAO | F Tax w/h | 2026-03-04 | 2026-03-06 | 750 | $204.86 | $153.6K | 35,196 | SEC↗ |
| Deppe Michael J | SVP, Corp. Controller & CAO | A Award | 2026-03-04 | 2026-03-06 | 1,473 | $204.86 | $301.8K | 35,946 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award | 2026-03-04 | 2026-03-06 | 5,682 | $204.86 | $1.16M | 20,880 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2026-03-04 | 2026-03-06 | 2,827 | $204.86 | $579.1K | 18,053 | SEC↗ |
| Davis J. E. | CEO and President | A Award | 2026-03-04 | 2026-03-06 | 51,652 | $204.86 | $10.58M | 168,837 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2026-03-04 | 2026-03-06 | 26,414 | $204.86 | $5.41M | 142,423 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | A Award | 2026-03-04 | 2026-03-06 | 7,232 | $204.86 | $1.48M | 44,789 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2026-03-04 | 2026-03-06 | 3,354 | $204.86 | $687.1K | 41,435 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2026-03-04 | 2026-03-06 | 2,326 | $204.86 | $476.5K | 11,864 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | A Award | 2026-03-04 | 2026-03-06 | 5,682 | $204.86 | $1.16M | 14,190 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | A Award | 2026-03-04 | 2026-03-06 | 11,364 | $204.86 | $2.33M | 78,486 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | F Tax w/h | 2026-03-04 | 2026-03-06 | 5,806 | $204.86 | $1.19M | 72,680 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2026-03-04 | 2026-03-06 | 7,720 | $204.86 | $1.58M | 33,268 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2026-03-04 | 2026-03-06 | 13,947 | $204.86 | $2.86M | 40,988 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2026-03-03 | 2026-03-04 | 410 | $207.73 | $85.2K | 15,198 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-03-03 | 2026-03-04 | 526 | $207.73 | $109.3K | 37,557 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-03-03 | 2026-03-04 | 632 | $207.73 | $131.3K | 67,122 | SEC↗ |
| Deppe Michael J | SVP, Corp. Controller & CAO | F Tax w/h | 2026-03-02 | 2026-03-04 | 88 | $204.86 | $18.0K | 34,473 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2026-03-02 | 2026-03-04 | 188 | $204.86 | $38.5K | 8,508 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2026-03-02 | 2026-03-04 | 205 | $204.86 | $42.0K | 9,869 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2026-03-02 | 2026-03-04 | 230 | $204.86 | $47.1K | 15,608 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2026-03-02 | 2026-03-04 | 10,000 | $212.52 | $2.13M | 117,185 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2026-03-02 | 2026-03-04 | 2,968 | $204.86 | $608.0K | 127,185 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2026-03-02 | 2026-03-04 | 288 | $204.86 | $59.0K | 38,083 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2026-03-02 | 2026-03-04 | 869 | $204.86 | $178.0K | 27,041 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | F Tax w/h | 2026-03-02 | 2026-03-04 | 648 | $204.86 | $132.7K | 67,754 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-02-19 | 2026-02-20 | 1,433 | $204.83 | $293.5K | 68,402 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2026-02-19 | 2026-02-20 | 1,111 | $204.83 | $227.6K | 38,371 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2026-02-19 | 2026-02-20 | 958 | $204.83 | $196.2K | 15,838 | SEC↗ |
| Deppe Michael J | SVP, Corp. Controller & CAO | A Award deriv | 2026-02-18 | 2026-02-20 | 1,688 | — | $0 | 1,688 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | A Award deriv | 2026-02-18 | 2026-02-20 | 7,332 | — | $0 | 7,332 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A Award deriv | 2026-02-18 | 2026-02-20 | 9,853 | — | $0 | 9,853 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | A Award deriv | 2026-02-18 | 2026-02-20 | 13,514 | — | $0 | 13,514 | SEC↗ |
| Davis J. E. | CEO and President | A Award deriv | 2026-02-18 | 2026-02-20 | 73,225 | — | $0 | 73,225 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | A Award deriv | 2026-02-18 | 2026-02-20 | 9,289 | — | $0 | 9,289 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award deriv | 2026-02-18 | 2026-02-20 | 18,303 | — | $0 | 18,303 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award deriv | 2026-02-18 | 2026-02-20 | 9,009 | — | $0 | 9,009 | SEC↗ |
| Deppe Michael J | SVP, Corp. Controller & CAO | A Award | 2026-02-18 | 2026-02-20 | 366 | — | $0 | 34,742 | SEC↗ |
| Deppe Michael J | SVP, Corp. Controller & CAO | F Tax w/h | 2026-02-18 | 2026-02-20 | 83 | $210.01 | $17.4K | 34,659 | SEC↗ |
| Deppe Michael J | SVP, Corp. Controller & CAO | F Tax w/h | 2026-02-18 | 2026-02-20 | 99 | $206.99 | $20.5K | 34,560 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2026-02-18 | 2026-02-20 | 205 | $210.01 | $43.1K | 8,911 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2026-02-18 | 2026-02-20 | 230 | $206.99 | $47.6K | 8,681 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | A Award | 2026-02-18 | 2026-02-20 | 1,586 | — | $0 | 9,116 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A Award | 2026-02-18 | 2026-02-20 | 2,135 | — | $0 | 10,049 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2026-02-18 | 2026-02-20 | 252 | $210.01 | $52.9K | 8,173 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2026-02-18 | 2026-02-20 | 259 | $206.99 | $53.6K | 7,914 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | F Tax w/h | 2026-02-18 | 2026-02-20 | 728 | $206.99 | $150.7K | 69,835 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | F Tax w/h | 2026-02-18 | 2026-02-20 | 433 | $210.01 | $90.9K | 70,563 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | A Award | 2026-02-18 | 2026-02-20 | 2,928 | — | $0 | 70,996 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2026-02-18 | 2026-02-20 | 3,788 | $206.99 | $784.1K | 130,153 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2026-02-18 | 2026-02-20 | 2,396 | $210.01 | $503.2K | 133,941 | SEC↗ |
| Davis J. E. | CEO and President | A Award | 2026-02-18 | 2026-02-20 | 15,857 | — | $0 | 136,337 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | A Award | 2026-02-18 | 2026-02-20 | 2,013 | — | $0 | 40,130 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2026-02-18 | 2026-02-20 | 301 | $210.01 | $63.2K | 39,829 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2026-02-18 | 2026-02-20 | 347 | $206.99 | $71.8K | 39,482 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2026-02-18 | 2026-02-20 | 3,965 | — | $0 | 29,706 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2026-02-18 | 2026-02-20 | 855 | $210.01 | $179.6K | 28,851 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2026-02-18 | 2026-02-20 | 1,010 | $206.99 | $209.1K | 27,841 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award | 2026-02-18 | 2026-02-20 | 1,952 | — | $0 | 17,333 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2026-02-18 | 2026-02-20 | 244 | $210.01 | $51.2K | 17,089 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2026-02-18 | 2026-02-20 | 293 | $206.99 | $60.6K | 16,796 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | M Exercise deriv | 2026-02-13 | 2026-02-17 | 26,165 | $112.17 | $2.93M | 0 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-02-13 | 2026-02-17 | 3,500 | $207.08 | $724.8K | 70,038 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-02-13 | 2026-02-17 | 1,619 | $208.21 | $337.1K | 68,419 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-02-13 | 2026-02-17 | 351 | $209.10 | $73.4K | 68,068 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-02-13 | 2026-02-17 | 10,573 | $205.21 | $2.17M | 83,660 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2026-02-13 | 2026-02-17 | 10,122 | $206.37 | $2.09M | 73,538 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | M Exercise | 2026-02-13 | 2026-02-17 | 26,165 | $112.17 | $2.93M | 94,233 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | M Exercise deriv | 2026-02-10 | 2026-02-12 | 5,662 | $121.81 | $689.7K | 0 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | M Exercise | 2026-02-10 | 2026-02-12 | 5,662 | $121.81 | $689.7K | 21,043 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2026-02-10 | 2026-02-12 | 5,662 | $204.00 | $1.16M | 15,381 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award | 2026-01-28 | 2026-02-12 | 48 | $183.51 | $8.8K | 15,381 | SEC↗ |
| Gregg Vicky B | Director | L Small acq | 2026-01-28 | 2026-02-20 | 67 | $183.51 | $12.3K | 17,104 | SEC↗ |
| CARTER ROBERT B | Director | L Small acq | 2026-01-28 | 2026-02-20 | 6 | $183.51 | $1.1K | 2,704 | SEC↗ |
| Lassiter Wright III | Director | L Small acq | 2026-01-28 | 2026-02-20 | 7 | $183.51 | $1.3K | 9,057 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | L Small acq | 2026-01-28 | 2026-02-20 | 15 | $183.51 | $2.8K | 8,696 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small acq | 2026-01-28 | 2026-02-20 | 16 | $183.52 | $2.9K | 10,065 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2026-01-28 | 2026-02-20 | 69 | $183.51 | $12.7K | 27,910 | SEC↗ |
| Davis J. E. | CEO and President | M Exercise deriv | 2025-11-25 | 2025-11-28 | 55,093 | $95.80 | $5.28M | 0 | SEC↗ |
| Gregg Vicky B | Director | S Sale | 2025-11-25 | 2025-11-28 | 1,250 | $191.76 | $239.7K | 17,037 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-11-25 | 2025-11-28 | 41,004 | $192.27 | $7.88M | 125,227 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-11-25 | 2025-11-28 | 4,747 | $192.97 | $916.0K | 120,480 | SEC↗ |
| Davis J. E. | CEO and President | M Exercise | 2025-11-25 | 2025-11-28 | 55,093 | $95.80 | $5.28M | 175,573 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-11-25 | 2025-11-28 | 9,342 | $191.59 | $1.79M | 166,231 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | M Exercise deriv | 2025-11-18 | 2025-11-20 | 100 | $143.33 | $14.3K | 7,484 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | M Exercise deriv | 2025-11-18 | 2025-11-20 | 7,846 | $144.47 | $1.13M | 0 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | M Exercise | 2025-11-18 | 2025-11-20 | 100 | $143.33 | $14.3K | 15,476 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | S Sale | 2025-11-18 | 2025-11-20 | 7,946 | $187.35 | $1.49M | 7,530 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | M Exercise | 2025-11-18 | 2025-11-20 | 7,846 | $144.47 | $1.13M | 15,376 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2025-11-05 | 2025-11-07 | 7,143 | $175.57 | $1.25M | 120,480 | SEC↗ |
| PFEIFFER GARY M | Director | I Discretionary deriv | 2025-10-23 | 2025-10-24 | 4,413 | $190.58 | $841.1K | 0 | SEC↗ |
| PFEIFFER GARY M | Director | S Sale | 2025-10-22 | 2025-10-24 | 1,482 | $182.40 | $270.3K | 29,431 | SEC↗ |
| CARTER ROBERT B | Director | A Award | 2025-10-21 | 2025-10-24 | 6 | $189.09 | $1.1K | 2,698 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | A Award | 2025-10-21 | 2025-10-24 | 15 | $189.08 | $2.8K | 7,530 | SEC↗ |
| Gregg Vicky B | Director | A Award | 2025-10-21 | 2025-10-24 | 70 | $189.08 | $13.2K | 18,287 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A Award | 2025-10-21 | 2025-10-24 | 15 | $189.08 | $2.8K | 8,379 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award | 2025-10-21 | 2025-10-24 | 46 | $189.08 | $8.7K | 15,333 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2025-10-21 | 2025-10-24 | 68 | $189.08 | $12.9K | 25,741 | SEC↗ |
| Lassiter Wright III | Director | A Award deriv | 2025-10-01 | 2025-10-03 | 157 | — | $0 | 679 | SEC↗ |
| RING TIMOTHY M | Director | A Award deriv | 2025-10-01 | 2025-10-03 | 233 | — | $0 | 17,037 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise deriv | 2025-09-26 | 2025-09-30 | 227 | $103.57 | $23.5K | 0 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-09-26 | 2025-09-30 | 144 | $188.66 | $27.2K | 38,117 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-09-26 | 2025-09-30 | 83 | $187.22 | $15.5K | 38,261 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise | 2025-09-26 | 2025-09-30 | 227 | $103.57 | $23.5K | 38,344 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise deriv | 2025-09-24 | 2025-09-25 | 175 | $103.57 | $18.1K | 227 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise | 2025-09-24 | 2025-09-25 | 175 | $103.57 | $18.1K | 38,292 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-09-24 | 2025-09-25 | 175 | $187.02 | $32.7K | 38,117 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise deriv | 2025-09-23 | 2025-09-25 | 28,288 | $103.57 | $2.93M | 402 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | M Exercise | 2025-09-23 | 2025-09-25 | 28,288 | $103.57 | $2.93M | 66,405 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-09-23 | 2025-09-25 | 28,288 | $187.12 | $5.29M | 38,117 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2025-08-21 | 2025-08-25 | 1,975 | $185.00 | $365.4K | 15,269 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | M Exercise deriv | 2025-08-19 | 2025-08-21 | 4,532 | $112.17 | $508.4K | 0 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2025-08-19 | 2025-08-21 | 4,532 | $183.00 | $829.4K | 17,244 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | M Exercise | 2025-08-19 | 2025-08-21 | 4,532 | $112.17 | $508.4K | 21,776 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2025-08-15 | 2025-08-19 | 1,975 | $180.00 | $355.5K | 17,244 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2025-08-13 | 2025-08-15 | 123 | $175.91 | $21.6K | 8,338 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | M Exercise deriv | 2025-08-06 | 2025-08-08 | 3,560 | $86.63 | $308.4K | 0 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | M Exercise | 2025-08-06 | 2025-08-08 | 3,560 | $86.63 | $308.4K | 24,745 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2025-08-06 | 2025-08-08 | 3,560 | $175.00 | $623.0K | 21,185 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2025-08-06 | 2025-08-08 | 1,975 | $175.00 | $345.6K | 19,219 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S Sale | 2025-07-31 | 2025-08-01 | 2,210 | $170.00 | $375.7K | 8,450 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise deriv | 2025-07-30 | 2025-08-01 | 5,224 | $112.17 | $586.0K | 0 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise deriv | 2025-07-30 | 2025-08-01 | 3,045 | $86.63 | $263.8K | 0 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 2025-07-30 | 2025-08-01 | 5,224 | $112.17 | $586.0K | 15,884 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S Sale | 2025-07-30 | 2025-08-01 | 5,224 | $167.40 | $874.5K | 10,660 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S Sale | 2025-07-30 | 2025-08-01 | 3,045 | $167.40 | $509.7K | 10,660 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | M Exercise | 2025-07-30 | 2025-08-01 | 3,045 | $86.63 | $263.8K | 13,705 | SEC↗ |
| CARTER ROBERT B | Director | L Small acq | 2025-07-21 | 2025-07-25 | 7 | $167.51 | $1.2K | 2,692 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | L Small acq | 2025-07-21 | 2025-07-25 | 17 | $167.49 | $2.8K | 7,515 | SEC↗ |
| Gregg Vicky B | Director | L Small acq | 2025-07-21 | 2025-07-25 | 79 | $167.50 | $13.2K | 18,217 | SEC↗ |
| Lassiter Wright III | Director | L Small acq | 2025-07-21 | 2025-07-25 | 7 | $167.51 | $1.2K | 9,044 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small acq | 2025-07-21 | 2025-07-25 | 27 | $167.50 | $4.5K | 10,660 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | L Small acq | 2025-07-21 | 2025-07-25 | 80 | $167.49 | $13.4K | 21,185 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | L Small acq | 2025-07-21 | 2025-07-25 | 72 | $167.50 | $12.1K | 25,673 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2025-07-16 | 2025-07-17 | 850 | $169.01 | $143.7K | 25,601 | SEC↗ |
| Lassiter Wright III | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 160 | — | $0 | 521 | SEC↗ |
| RING TIMOTHY M | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 236 | — | $0 | 16,725 | SEC↗ |
| PFEIFFER GARY M | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 30,669 | SEC↗ |
| RING TIMOTHY M | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 29,507 | SEC↗ |
| Lassiter Wright III | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 9,037 | SEC↗ |
| MORRISON DENISE M | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 10,742 | SEC↗ |
| MAIN TIMOTHY L | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 26,297 | SEC↗ |
| Doi Tracey | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 6,490 | SEC↗ |
| Gregg Vicky B | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 18,138 | SEC↗ |
| Diaz Luis | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 4,054 | SEC↗ |
| CARTER ROBERT B | Director | A Award | 2025-05-15 | 2025-05-19 | 1,203 | — | $0 | 2,685 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | S Sale | 2025-05-13 | 2025-05-14 | 874 | $175.31 | $153.2K | 7,498 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | S Sale | 2025-05-12 | 2025-05-14 | 874 | $175.72 | $153.6K | 8,372 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | L Small acq | 2025-04-21 | 2025-05-02 | 25 | $164.42 | $4.1K | 9,246 | SEC↗ |
| Gregg Vicky B | Director | A Award | 2025-04-21 | 2025-05-02 | 68 | $164.42 | $11.2K | 16,935 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | L Small acq | 2025-04-21 | 2025-05-02 | 81 | $164.42 | $13.3K | 21,087 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | L Small acq | 2025-04-21 | 2025-05-02 | 27 | $164.42 | $4.4K | 10,612 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | L Small acq | 2025-04-21 | 2025-05-02 | 74 | $164.42 | $12.2K | 26,451 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S Sale | 2025-04-02 | 2025-04-04 | 2,555 | $170.00 | $434.4K | 10,575 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 750 | $167.86 | $125.9K | 131,322 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 2,493 | $169.57 | $422.7K | 132,072 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 2,366 | $168.03 | $397.6K | 164,448 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 1,411 | $168.76 | $238.1K | 163,037 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 704 | $169.63 | $119.4K | 162,333 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 7,249 | $167.86 | $1.22M | 155,084 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 4,905 | $168.72 | $827.6K | 150,179 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 2,764 | $169.56 | $468.7K | 147,415 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 6,950 | $167.86 | $1.17M | 140,465 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 453 | $169.63 | $76.8K | 127,623 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 902 | $168.79 | $152.2K | 128,076 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 1,493 | $167.88 | $250.6K | 128,978 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 267 | $169.60 | $45.3K | 130,471 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 584 | $168.70 | $98.5K | 130,738 | SEC↗ |
| Davis J. E. | CEO and President | S Sale | 2025-04-02 | 2025-04-04 | 5,900 | $168.66 | $995.1K | 134,565 | SEC↗ |
| RING TIMOTHY M | Director | A Award deriv | 2025-04-01 | 2025-04-03 | 251 | — | $0 | 16,410 | SEC↗ |
| Lassiter Wright III | Director | A Award deriv | 2025-04-01 | 2025-04-03 | 169 | — | $0 | 360 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2025-03-26 | 2025-03-28 | 256 | $166.71 | $42.7K | 9,221 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2025-03-26 | 2025-03-28 | 162 | $166.71 | $27.0K | 20,988 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-03-17 | 2025-03-19 | 4,643 | $170.00 | $789.3K | 38,117 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2025-03-05 | 2025-03-07 | 5,370 | $174.13 | $935.1K | 68,068 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2025-03-04 | 2025-03-05 | 13,884 | $173.74 | $2.41M | 34,061 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2025-03-04 | 2025-03-05 | 7,684 | $173.74 | $1.34M | 26,377 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2025-03-04 | 2025-03-05 | 1,823 | $173.74 | $316.7K | 9,477 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | A Award | 2025-03-04 | 2025-03-05 | 5,317 | $173.74 | $923.8K | 11,300 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2025-03-04 | 2025-03-05 | 3,906 | $173.74 | $678.6K | 42,760 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-03-04 | 2025-03-05 | 592 | $175.79 | $104.1K | 38,117 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | A Award | 2025-03-04 | 2025-03-05 | 8,549 | $173.74 | $1.49M | 46,666 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award | 2025-03-04 | 2025-03-05 | 5,674 | $173.74 | $985.8K | 23,430 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2025-03-04 | 2025-03-05 | 2,280 | $173.74 | $396.1K | 21,150 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A Award | 2025-03-04 | 2025-03-05 | 4,434 | $173.74 | $770.4K | 14,998 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2025-03-04 | 2025-03-05 | 1,879 | $173.74 | $326.5K | 13,119 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2025-03-04 | 2025-03-05 | 31,656 | $173.74 | $5.50M | 166,814 | SEC↗ |
| Davis J. E. | CEO and President | A Award | 2025-03-04 | 2025-03-05 | 61,917 | $173.74 | $10.76M | 198,470 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | F Tax w/h | 2025-03-04 | 2025-03-05 | 5,010 | $173.74 | $870.4K | 73,438 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2025-03-04 | 2025-03-05 | 716 | $175.79 | $125.9K | 68,068 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | A Award | 2025-03-04 | 2025-03-05 | 10,380 | $173.74 | $1.80M | 78,448 | SEC↗ |
| DEPPE MICHAEL J | SVP, Corp. Controller & CAO | F Tax w/h | 2025-03-04 | 2025-03-05 | 867 | $173.74 | $150.6K | 34,365 | SEC↗ |
| DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A Award | 2025-03-04 | 2025-03-05 | 1,711 | $173.74 | $297.3K | 35,232 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2025-03-03 | 2025-03-05 | 322 | $173.74 | $55.9K | 38,709 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2025-03-03 | 2025-03-05 | 106 | $173.74 | $18.4K | 17,756 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2025-03-03 | 2025-03-05 | 992 | $173.74 | $172.4K | 10,564 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2025-03-03 | 2025-03-05 | 1,662 | $173.74 | $288.8K | 136,553 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | F Tax w/h | 2025-03-03 | 2025-03-05 | 394 | $173.74 | $68.5K | 68,784 | SEC↗ |
| DEPPE MICHAEL J | SVP, Corp. Controller & CAO | F Tax w/h | 2025-03-03 | 2025-03-05 | 1,692 | $173.74 | $294.0K | 33,521 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2025-02-27 | 2025-02-28 | 824 | $172.61 | $142.2K | 69,178 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-02-27 | 2025-02-28 | 528 | $172.61 | $91.1K | 39,031 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2025-02-26 | 2025-02-28 | 214 | $171.75 | $36.8K | 5,983 | SEC↗ |
| DEPPE MICHAEL J | SVP, Corp. Controller & CAO | F Tax w/h | 2025-02-26 | 2025-02-28 | 88 | $171.75 | $15.1K | 35,212 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | F Tax w/h | 2025-02-26 | 2025-02-28 | 455 | $171.75 | $78.1K | 70,002 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2025-02-26 | 2025-02-28 | 233 | $171.75 | $40.0K | 11,546 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | F Tax w/h | 2025-02-26 | 2025-02-28 | 229 | $171.75 | $39.3K | 17,853 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2025-02-26 | 2025-02-28 | 286 | $171.75 | $49.1K | 39,559 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2025-02-26 | 2025-02-28 | 2,966 | $171.75 | $509.4K | 138,215 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2025-02-26 | 2025-02-28 | 869 | $171.75 | $149.3K | 20,177 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2025-02-20 | 2025-02-21 | 899 | $170.99 | $153.7K | 70,457 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | S Sale | 2025-02-20 | 2025-02-21 | 604 | $170.99 | $103.3K | 39,845 | SEC↗ |
| Davis J. E. | CEO and President | F Tax w/h | 2025-02-19 | 2025-02-21 | 2,936 | $169.71 | $498.3K | 141,181 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | F Tax w/h | 2025-02-19 | 2025-02-21 | 242 | $169.71 | $41.1K | 6,197 | SEC↗ |
| DEPPE MICHAEL J | SVP, Corp. Controller & CAO | F Tax w/h | 2025-02-19 | 2025-02-21 | 99 | $169.71 | $16.8K | 35,300 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | S Sale | 2025-02-19 | 2025-02-21 | 535 | $169.71 | $90.8K | 71,356 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F Tax w/h | 2025-02-19 | 2025-02-21 | 287 | $169.71 | $48.7K | 11,779 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | S Sale | 2025-02-19 | 2025-02-21 | 320 | $169.71 | $54.3K | 18,082 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | F Tax w/h | 2025-02-19 | 2025-02-21 | 374 | $169.71 | $63.5K | 40,449 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | F Tax w/h | 2025-02-19 | 2025-02-21 | 1,031 | $169.71 | $175.0K | 21,046 | SEC↗ |
| DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A Award deriv | 2025-02-12 | 2025-02-14 | 1,738 | — | $0 | 1,738 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | A Award deriv | 2025-02-12 | 2025-02-14 | 6,960 | — | $0 | 6,960 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | A Award deriv | 2025-02-12 | 2025-02-14 | 13,344 | — | $0 | 13,344 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A Award deriv | 2025-02-12 | 2025-02-14 | 8,702 | — | $0 | 8,702 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award deriv | 2025-02-12 | 2025-02-14 | 7,833 | — | $0 | 7,833 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | A Award deriv | 2025-02-12 | 2025-02-14 | 8,991 | — | $0 | 8,991 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award deriv | 2025-02-12 | 2025-02-14 | 17,403 | — | $0 | 17,403 | SEC↗ |
| Davis J. E. | CEO and President | A Award deriv | 2025-02-12 | 2025-02-14 | 69,633 | — | $0 | 69,633 | SEC↗ |
| DEPPE MICHAEL J | SVP, Corp. Controller & CAO | A Award | 2025-02-12 | 2025-02-14 | 454 | — | $0 | 35,399 | SEC↗ |
| DELANEY MARK E | SVP & Chief Commercial Offic | A Award | 2025-02-12 | 2025-02-14 | 1,815 | — | $0 | 6,439 | SEC↗ |
| Doherty Catherine T. | EVP, Regional Businesses | A Award | 2025-02-12 | 2025-02-14 | 3,479 | — | $0 | 71,891 | SEC↗ |
| KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A Award | 2025-02-12 | 2025-02-14 | 2,269 | — | $0 | 12,066 | SEC↗ |
| Plewman Patrick | SVP for Diagnostic Services | A Award | 2025-02-12 | 2025-02-14 | 2,042 | — | $0 | 18,402 | SEC↗ |
| PREVOZNIK MICHAEL E | SVP & General Counsel | A Award | 2025-02-12 | 2025-02-14 | 2,345 | — | $0 | 40,823 | SEC↗ |
| SAMAD SAM | Executive Vice President & C | A Award | 2025-02-12 | 2025-02-14 | 4,538 | — | $0 | 22,077 | SEC↗ |
| Davis J. E. | CEO and President | A Award | 2025-02-12 | 2025-02-14 | 18,149 | — | $0 | 144,117 | SEC↗ |